Robbert J. Kok
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
-
- Angiogenesis and VEGF in Cancer 15
- RNA Interference and Gene Delivery 13
- Renal and related cancers 8
- Biomaterials 29
- Nanoparticle-Based Drug Delivery 23
- Co-authors
- Wim E. Hennink (43 shared papers)Grietje Molema (26 shared papers)Gert Storm (23 shared papers)Raymond M. Schiffelers (14 shared papers)Kai Temming (13 shared papers)Dirk K. F. Meijer (19 shared papers)Roel Goldschmeding (14 shared papers)Tri Q. Nguyen (11 shared papers)
- Journals
- Journal of Controlled Release (14 papers)International Journal of Pharmaceutics (11 papers)Pharmaceutical Research (7 papers)Bioconjugate Chemistry (6 papers)Molecular Pharmaceutics (6 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Robbert J. Kok
136 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 136
- Biomaterials 1.7k
- Pharmaceutical Science 614
- Immunology and Allergy 496
- Nephrology 462
- Molecular Biology 3.0k
Countries citing papers authored by Robbert J. Kok
This map shows the geographic impact of Robbert J. Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robbert J. Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robbert J. Kok more than expected).
Fields of papers citing papers by Robbert J. Kok
This network shows the impact of papers produced by Robbert J. Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robbert J. Kok. The network helps show where Robbert J. Kok may publish in the future.
Co-authors
The 25 scholars most cited alongside Robbert J. Kok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 395 | |
| 2 | 2013 | 306 | |
| 3 | 2015 | 231 | |
| 4 | 2016 | 226 | |
| 5 | 2016 | 213 | |
| 6 | 2006 | 211 | |
| 7 | 2013 | 177 | |
| 8 | 2006 | 150 | |
| 9 | 2010 | 139 | |
| 10 | 2005 | 127 | |
| 11 | 2001 | 126 | |
| 12 | 2009 | 114 | |
| 13 | 2013 | 111 | |
| 14 | 2004 | 107 | |
| 15 | 2010 | 105 | |
| 16 | 2012 | 101 | |
| 17 | 2011 | 98 | |
| 18 | 2012 | 97 | |
| 19 | 2010 | 88 | |
| 20 | 2014 | 85 |
About Robbert J. Kok
Robbert J. Kok is a scholar working on Molecular Biology, Biomaterials, Immunology and Allergy, Oncology and Nephrology, having authored 136 papers that have together received 6.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (23 papers), Cell Adhesion Molecules Research (23 papers), Angiogenesis and VEGF in Cancer (15 papers), RNA Interference and Gene Delivery (13 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Drug Delivery Systems (10 papers), Renal and related cancers (8 papers) and Renal Diseases and Glomerulopathies (7 papers). The work is most often cited by research in Biomaterials (1.7k citations), Pharmaceutical Science (614 citations), Immunology and Allergy (496 citations), Nephrology (462 citations) and Molecular Biology (3.0k citations). Robbert J. Kok has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Wim E. Hennink, Grietje Molema, Gert Storm, Raymond M. Schiffelers, Kai Temming, Dirk K. F. Meijer, Roel Goldschmeding, Tri Q. Nguyen, Roy van der Meel and Ethlinn V.B. van Gaal. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Pharmaceutical Research, Bioconjugate Chemistry and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.